SEC Form 4 · accession 0000899243-16-028840
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Sep 8, 2016
Accepted (ET)
Sep 12, 2016 · 9:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2016 | M | 31,269 | $10.29 | A | 648,307 | D | |
| Common StockF3,F1,F4 | Sep 8, 2016 | S | 31,269 | $50.0808 | D | 638,835 | D | |
| Common StockF4 | Sep 10, 2016 | G | 6,148 | $0.00 | D | 0 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $10.29 | Sep 8, 2016 | M | 31,269 | D | — | Aug 28, 2017 | Common Stock | 31,269 | 115,443 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $50.00 to $50.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4The Reporting Person previously contributed shares of SGEN common stock to a grantor retained annuity trust for the benefit of himself and trusts for his children. Upon the termination of the trust on September 10, 2016, 6,148 of the shares were transferred to the Reporting Person's children's trusts and the remaining 21,797 shares were transferred to the Reporting Person and are included in the reported number of shares directly owned by the Reporting Person.
- F5Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11.